303. Clinical Trials Aren't a Last Resort: What Every Breast Cancer Patient Should Know

Love the podcast? Send us a text! When many people hear the words "clinical trial," they immediately think of a last resort. But that's one of the biggest misconceptions in breast cancer care. In this episode of Breast Cancer Conversations , host Laura Carfang sits down with Dr. Ada Waks , breast medical oncologist and clinical investigator at Dana-Farber Cancer Institute, to demystify clinical trials and explain how they are shaping the future of breast cancer treatment. Dr. Waks cares for patients across all stages of breast cancer while leading clinical research that helps develop tomorrow's treatments. Together, Laura and Dr. Waks discuss how clinical trials work, who they are designed for, and why patients should consider asking about them much earlier in their treatment journey. In this episode, you'll learn: What a clinical trial actually is The difference between Phase I, II, and III trials Randomized vs. blinded clinical trials Why clinical trials are not just for patients who have run out of treatment options How new breast cancer drugs become FDA-approved What informed consent really means How patient safety is protected Why clinical trial participants often receive additional monitoring and support How to find clinical trials that may be right for you The future of personalized breast cancer treatment Whether you're newly diagnosed, living with metastatic breast cancer, navigating survivorship, or supporting a loved one, this episode provides an accessible introduction to one of the most important—and most misunderstood—aspects of cancer care. About Today's Guest Dr. Ada Waks is a breast medical oncologist and clinical investigator at Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School. She divides her time between caring for patients with breast cancer and leading clinical research focused on developing safer, more effective, and more personalized treatments. Dr. Waks also co-directs Dana-Farber's breast oncology clinical trials program, helping bring innovative therapies from the laboratory to patients. Support the show Listener Feedback Please share a review with us! If this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify and share some stars! You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback. Messages are completely anonymous. If you would like us to follow up directly, please include your email address in your message so we can respond. Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Enjoying our content? Please consider supporting our work .

303. Clinical Trials Aren't a Last Resort: What Every Breast Cancer Patient Should Know | Dr. Ada Waks